BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23995525)

  • 1. [Long-term survival with gemcitabine and docetaxel for renal leiomyosarcoma : a case report].
    Nagumo Y; Kimura T; Ichioka D; Uchida M; Oikawa T; Suetomi T; Miyazaki J; Kawai K; Nagata C; Nishiyama H
    Hinyokika Kiyo; 2013 Aug; 59(8):497-501. PubMed ID: 23995525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases].
    Murakami J; Hori K; Okubo R; Miyagi K; Shiomi M; Uragami K; Nakagawa M; Yoshioka E; Tsuruta T; Tashima R; Ito K
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):259-61. PubMed ID: 27067695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes.
    Littell RD; Tucker LY; Raine-Bennett T; Palen TE; Zaritsky E; Neugebauer R; Embry-Schubert J; Lentz SE
    Gynecol Oncol; 2017 Oct; 147(1):11-17. PubMed ID: 28747255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term].
    Hayashi T; Nakai Y; Kakuta Y; Takayama H; Nakayama M; Nonomura N; Okumi M; Nakao A
    Hinyokika Kiyo; 2010 Sep; 56(9):527-30. PubMed ID: 20940530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
    Hensley ML; Ishill N; Soslow R; Larkin J; Abu-Rustum N; Sabbatini P; Konner J; Tew W; Spriggs D; Aghajanian CA
    Gynecol Oncol; 2009 Mar; 112(3):563-7. PubMed ID: 19135708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac metastasis from uterine leiomyosarcoma.
    Moreno Antón F; Casado Herraez A; Puente Vázquez J; Gómez Díaz R; Aragoncillo P; Díaz-Rubio García E
    Clin Transl Oncol; 2006 May; 8(5):375-8. PubMed ID: 16760015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma].
    Yao Z; Yang S; Zhao Y; Yao S; Guo H; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):541-5. PubMed ID: 25327662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral leiomyosarcoma of kidneys with pericardial metastases: a double whammy.
    Kumar S; Narain TA; Sharma G; Tyagi S
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30898939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
    Hensley ML; Maki R; Venkatraman E; Geller G; Lovegren M; Aghajanian C; Sabbatini P; Tong W; Barakat R; Spriggs DR
    J Clin Oncol; 2002 Jun; 20(12):2824-31. PubMed ID: 12065559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel.
    Sawhney R; Curry N; Burks T; Chaudhary UB
    Anticancer Drugs; 2007 Jul; 18(6):745-7. PubMed ID: 17762407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature.
    Mohanty SK; Balani JP; Parwani AV
    Urology; 2007 Sep; 70(3):591.e5-7. PubMed ID: 17905130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience.
    Ebeling P; Eisele L; Schuett P; Bauer S; Schuette J; Moritz T; Seeber S; Flasshove M
    Onkologie; 2008 Feb; 31(1-2):11-6. PubMed ID: 18268394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature.
    Cauvin C; Moureau-Zabotto L; Chetaille B; Hilgers W; Denoux Y; Jacquemier J; Guiramand J; Sarran A; Bertucci F
    BMC Cancer; 2011 Jul; 11():323. PubMed ID: 21801386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.
    Hensley ML; Miller A; O'Malley DM; Mannel RS; Behbakht K; Bakkum-Gamez JN; Michael H
    J Clin Oncol; 2015 Apr; 33(10):1180-5. PubMed ID: 25713428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
    Takano T; Niikura H; Ito K; Nagase S; Utsunomiya H; Otsuki T; Toyoshima M; Tokunaga H; Kaiho-Sakuma M; Shiga N; Nagai T; Tanaka S; Otsuki A; Kurosawa H; Shigeta S; Tsuji K; Yamaguchi T; Yaegashi N
    Int J Clin Oncol; 2014 Oct; 19(5):897-905. PubMed ID: 24149774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation.
    Merimsky O
    Int J Mol Med; 2004 Nov; 14(5):931-5. PubMed ID: 15492868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
    Skarlos DV; Dimopoulos AM; Kosmidis P; Papakostas P; Pavlidis N; Bacoyiannis C; Kiamouris C; Klouvas G; Gogas H; Fountzilas G; Samantas E;
    Lung Cancer; 2003 Jul; 41(1):107-11. PubMed ID: 12826319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
    Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH
    Cancer; 2013 Apr; 119(8):1555-61. PubMed ID: 23335221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.